Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons

Neurobiology of Disease

Volumn 17, Issue 2, 2004, Pages 163-170

  Grothe, C ^a   Timmer, M ^a   Scholz, T ^a   Winkler, C ^a   Nikkhah, G ^b   Claus, P ^a   Itoh, N ^c   Arenas, E ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c KYOTO UNIVERSITY   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell therapy; Co culture; Differentiation; Dopamine; Fibroblast growth factor; Neural stem cell line; Nurr1; Parkinson's disease; Schwann cell; Tyrosine hydroxylase

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 20; FIBROBLAST GROWTH FACTOR RECEPTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CELL TRANSPLANTATION; COCULTURE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GLIA; IMMUNOCYTOCHEMISTRY; NONHUMAN; PARACRINE SIGNALING; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; STEM CELL; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ANIMALS; BRAIN DISEASES; CELL DIFFERENTIATION; CELL LINE; CORPUS STRIATUM; DNA-BINDING PROTEINS; DOPAMINE; FIBROBLAST GROWTH FACTORS; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; MICE; NEURONS; OXIDOPAMINE; PHENOTYPE; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 5144226353     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.07.007     Document Type: Article

References (47)

1. Y.H. Ahn, M. Emgard, and P. Brundin Ultrastructural characterization of dissociated embryonic ventral mesencephalic tissue treated with neuroprotectants Cell Transplant. 12 3 2003 235 241
2. R.A. Barker, S.B. Dunnett, A. Faissner, and J.W. Fawcett The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum Exp. Neurol. 141 1996 79 93
3. R.L. Branton, and D.J. Clarke Apoptosis in primary cultures of E14 rat ventral mesencephala: time course of dopaminergic cell death and implications for neural transplantation Exp. Neurol. 160 1 1999 88 98
4. P. Brundin, J. Karlsson, M. Emgård, G.S. Schierle, O. Hansson, Ã.... Petersén, and R.F. Castilho Improving the survival of grafted dopaminergic neurons: a review over current approaches Cell Transplant. 9 2000 179 195
5. G. Castelo-Branco, J. Wagner, F.J. Rodriguez, J. Kele, K. Sousa, N. Rawal, H.A. Pasolli, E. Fuchs, J. Kitajewski, and E. Arenas Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a Proc. Natl. Acad. Sci. U. S. A. 100 2003 12747 12752
6. S.O. Castillo, J.S. Baffi, M. Palkovits, D.S. Goldstein, I.J. Kopin, J. Witta, M.A. Magnuson, and V.M. Nikodem Dopaminergic biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene Mol. Cell. Neurosci. 11 1998 36 46
7. S. Chung, K.-C. Sonntag, T. Andersson, L.M. Björklund, J.J. Park, D.W. Kim, U.J. Kang, O. Isacson, and K.-S. Kim Genetic engineering of mouse embryonic stem cell by Nurr1 enhances differentiation and maturation into dopaminergic neurons Eur. J. Neurosci. 16 2002 1829 1838
8. P. Claus, S. Werner, M. Timmer, and C. Grothe Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease Neurosci. Lett. 360 3 2004 117 120
9. S.B. Dunnett Neural transplantation in animal models of dementia Eur. J. Neurosci. 2 1990 567 587
10. S.B. Dunnett, and A. Bjorklund Prospects for new restorative and neuroprotective treatments in Parkinson's disease Nature 399 1999 A32 A39
11. S.B. Dunnett, A. Björklund, and O. Lindvall Cell therapy in Parkinson's disease-Stop or go? Nat. Rev., Neurosci. 265 2001 365 369
12. M. Emgard, J. Karlsson, O. Hansson, and P. Brundin Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts Exp. Neurol. 160 1999 279 288
13. J. Engele, and M.C. Bohn The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia J. Neurosci. 11 1991 3070 3078
14. T.B. Freeman, P.R. Sanberg, G.M. Nauert, B.D. Boss, D. Spector, C.S. Olanow, and J.H. Kordower The influences of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts Cell Transplant. 4 1995 141 154
15. C. Grothe, C. Meisinger, A. Hertenstein, H. Kurz, and K. Wewetzer Expression of FGF-2 and FGF receptor type 1 mRNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion Neuroscience 76 1997 123 135
16. C. Grothe, A. Schulze, I. Semkova, F. Müller-Ostermeyer, A. Rege, and K. Wewetzer The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro Neuroscience 100 2000 73 86
17. C. Grothe, C. Meisinger, and P. Claus In vivo expression and localization of the fibroblast growth factor system in the intact and lesioned rat peripheral nerve and spinal ganglia J. Comp. Neurol. 434 2001 342 357
18. T. Hagg, and S. Varon Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo Proc. Natl. Acad. Sci. U. S. A. 90 1993 6315 6319
19. M.K. Hajihosseini, and J.K. Heath Expression patterns of fibroblast growth factors-18 and-20 in mouse embryos is suggestive of novel roles in calvarial and limb development Mech. Dev. 113 2002 79 83
20. A.C. Hall, H. Mira, J. Wagner, and E. Arenas Region-specific effects of glia on neuronal induction and differentiation with a focus on dopaminergic neurons Glia 43 2003 47 51
21. J.H. Kim, J.M. Auerbach, J.A. RodriguezGomez, I. Velasco, D. Gavin, N. Lumelsky, S.H. Lee, J. Nguyen, R. SanchezPernaute, K. Bankiewicz, and R. McKay Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50 56
22. J.-Y. Kim, H.C. Koh, J.-Y. Lee, M.-Y. Chang, Y.-C. Kim, H.-Y. Chung, H. Son, Y.-S. Lee, L. Studer, R. McKay, and S.-H. Lee Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression J. Neurochem. 85 2003 1443 1454
23. E. Mayer, S.B. Dunnett, R. Pellitteri, and J.W. Fawcett Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons: I. effects in vitro Neuroscience 56 1993 379 388
24. E. Mayer, J.W. Fawcett, and S.B. Dunnett Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons-II. Effects on nigral transplants in vivo Neuroscience 56 1993 389 398
25. C. Meisinger, C. Zeschnigk, and C. Grothe Glucocorticoid increases FGF-2 mRNA specifically in neural crest-derived and neuronal tissue J. Biol. Chem. 271 1996 16520 16525
26. F. Müller-Ostermeyer, P. Claus, and C. Grothe Distinctive effects of rat fibroblast growth factor-2 isoforms on PC12 and Schwann cells Growth Factors 19 2001 175 191
27. G. Nikkhah, M. Olsson, J. Eberhard, C. Bentlage, M.G. Cunningham, and A. Bjorklund A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology Neuroscience 63 1994 57 72
28. S. Ohmachi, Y. Watanabe, T. Mikami, N. Kusu, T. Ibi, A. Akaike, and N. Itoh FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain Biochem. Biophys. Res. Commun. 277 2000 355 360
29. S. Ohmachi, T. Mikami, M. Konishi, A. Miyake, and N. Itoh Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c J. Neurosci. Res. 72 2003 436 443
30. J.M. Rosenstein Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation Exp. Neurol. 133 1995 1 6
31. O. Saucedo-Cardenas, J.D. Quintana-Hau, W.-D. Le, M.P. Smidt, J.J Cox, F. De Majo, J.P.H. Burbach, and O.M. Conneely Nurr1 is essential for the induction of the dopaminergic phenotype and survival of ventral mesencephalic late dopaminergic precursor neurons Proc. Natl. Acad. Sci. U. S. A. 95 1998 4013 4018
32. G.S. Schierle, O. Hansson, M. Leist, P. Nicotera, H. Widner, and P. Brundin Caspase inhibition reduces apoptosis and increases survival of nigral transplants Nat. Med. 5 1999 97 100
33. C.W. Shults, and T.A. Kimber Mesencephalic dopaminergic cells exhibit increased density of neural cell adhesion molecule and polysialic acid during development Brain Res. Dev. Brain Res. 65 1992 161 172
34. C.W. Shults, R. Hashimoto, R.M. Brady, and F.H. Gage Dopaminergic cells align along radial glia in the developing mesencephalon of the rat Neuroscience 38 1990 427 436
35. M.P. Smidt, H.S. van Schaick, C. Lanctot, J.J. Tremblay, J.J. Cox, A.A. van der Kleij, G. Wolterink, J. Drouin, and J.P. Burbach A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons Proc. Natl. Acad. Sci. U. S. A. 94 1997 13305 13310
36. M.P. Smidt, C.H. Asbreuk, J.J. Cox, H. Chen, R.L. Johnson, and J.P. Burbach A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b Nat. Neurosci. 3 2000 337 341
37. E.Y. Snyder, D.L. Deitcher, C. Walsh, S. Arnold-Aldea, E.A. Hartwieg, and C.L. Cepko Multipotent neural cell lines can engraft and participate in development of mouse cerebellum Cell 68 1992 33 51
38. C.E. Sortwell, M.R. Pitzer, and T.J. Collier Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival Exp. Neurol. 165 2000 268 277
39. L. Studer, V. Tabar, and R.D.G. McKay Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats Nat. Neurosci. 1 1998 290 295
40. G.I. Tennekoon, J. Yoshino, K.W.C. Peden, J. Bigbee, J.L. Rutkowski, Y. Kishimoto, G.H. DeVries, and G.M. McKhann Transfection of neonatal rat Schwann cells with SV-40 large T antigen gene under control of the metallothionein promoter J. Cell Biol. 105 1987 2315 2325
41. M. Timmer, V. Kloth, T. Scholz, C. Winkler, C. Grothe, and G. Nikkhah Enhanced functional recovery and reinnervation of intrastriatal dopamine-grafts co-transplanted with physiological Schwann cells over-expressing high molecular weight FGF-2 isoforms Exp. Neurol. 187 1 2004 118 136
42. J. Van der Walt, M.A. Noureddine, R. Kittappa, M.A. Hauser, W.K. Scott, R. McKay, F. Zhang, J.M. Stajich, K. Fujiwara, B.L. Scott, M.A. Pericak-Vance, J.M. Vance, and E.R. Martin Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease Am. J. Hum. Genet. 74 2004 1121 1127
43. J. Wagner, P. Akerud, D.S. Castro, P.C. Holm, J.M. Canals, E.Y. Snyder, T. Perlmann, and E. Arenas Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes Nat. Biotechnol. 17 1999 653 659
44. S. Weiss, B.A. Reynolds, A.L. Vescovi, C. Morshead, C.G. Craig, and D. van der Kooy Is there a neural stem cell in the mammalian forebrain? Trends Neurosci. 19 1996 387 393
45. C. Winkler, C. Bentlage, G. Nikkhah, M. Samii, and A. Björklund Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants Exp. Neurol. 155 1999 165 186
46. M. Yang, N.D. Stull, M.A. Berk, E.Y. Snyder, and L. Iacovitti Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat Exp. Neurol. 177 1 2002 50 60
47. R. Zetterstrom, L. Solomin, L. Jansson, B. Hoffer, L. Olson, and T. Perlmann Dopamine neuron agenesis in Nurr1-deficient mice Science 276 1997 248 250